Biomarker Assay Development Articles & Analysis
3 news found
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
Scientists from Creative Diagnostics can also work with clients to prevent early pitfalls with assay development by assessing the purposes and desired attributes of the assay while adhering to strict quality control guidelines from start to finish. Creative Diagnostics focuses on thorough optimization and validation of every aspect of ...
MODAG, a German biotechnology company focused on the development of disease-modifying small molecule therapeutics for neurodegenerative diseases, today announced the successful completion of its first clinical trial of anle138b (NCT04208152) in healthy volunteers. ...